AI/ML Innovations Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- John Paul Duffy
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Address
- 645 Fort Street Victoria BC Canada V8W 1G2
- IPO Date
- Oct 30, 1996
- Website
- aiml-innovations.com
- Similar Companies
- Business
- AI/ML Innovations Inc. is a Canada-based global technology company specializing in artificial intelligence (AI) and machine learning (ML) applications, primarily targeting the digital healthcare sector. Founded in 2009 and headquartered in Victoria, British Columbia, the company develops proprietary platforms that convert complex biometric data into actionable clinical insights to support earlier diagnosis, personalized treatment, and improved healthcare outcomes. Its core product offerings include AI-driven digital health solutions; patented neural network technology; smart sensor wearables and biometric data analysis tools marketed through its majority-owned subsidiary Health Gauge Inc.; and a growing portfolio of AI/ML-powered healthcare software applications accessible via the commercial portal Neural Net Store. The company also holds strategic investments and majority stakes in emerging digital health companies such as Tech2Heal, AI Rx Inc., and NeuralCloud Solutions Inc. Recent major developments include the December 2024 acquisition of Quantum Sciences Ltd., which expands AI/ML Innovations’ capabilities into cardio AI-driven healthcare technologies addressing cardiovascular, neurodegenerative, and metabolic diseases; the launch of Health Gauge's innovative “Pulse Whisperer” product suite for biometric raw signal data aimed at life sciences researchers; and the completion of technology acquisitions from Naiad Lab Inc. These strategic moves strengthen the company's position in AI-based personalized medicine and digital health management globally, leveraging AI, ML, cloud computing, and data analytics to transform healthcare delivery across multiple markets.
AI/ML Subsidiary NeuralCloud Appoints Cardiac Monitoring Veterans Dale and Nicholas DuBois to Lead Clinical and Overread Operations
AI/ML Innovations Inc. Announces Closing of Final Tranche of Private Placement to Raise $1,917,500
AIML Appoints Dr. Martin Green to Medical Advisory Board and Issue Options
AI/ML Innovations Announces Completion of Share Issuance
AI/ML Innovations Announces Completion of Share Issuance
Neural Cloud Signs Reseller Agreement with European Digital Cardiac Monitoring Platform
AI/ML Innovations Inc. Announces Closing of First Tranche of Private Placement to Raise $950,000
AIML Subsidiary NeuralCloud Enters Research Services Agreement with Baker Heart and Diabetes Institute to Support AI-Driven ECG Analysis
AI/ML Innovations Inc. Announces Proposed Private Placement of Convertible Debentures
Neural Cloud Enters Distribution Agreement with Intelimed to Expand into Latin America
AIML Subsidiary NeuralCloud Signs Non-Binding Agreement with Movesense to Pilot AI-Powered ECG and Holter Reporting
Neural Cloud Retains Commission Wolf to Accelerate U.S. Commercial Expansion
AIML Appoints Dr. Paul Dorian as Medical Innovation Architect and Head of the Medical Advisory Board
AIML Subsidiary NeuralCloud Collaborates with Movesense to Expand Bundled ECG Solutions for Clinical and Wellness Markets
AIML subsidiary NeuralCloud Solutions Inc., Signs Non-Binding Commercial Term Sheet with Lakeshore Cardiology to Deploy CardioYield(TM) for AI-Powered Holter Analysis
AI/ML Appoints Erik Suokas as Chief Operating Officer to Accelerate Commercial Execution and Operational Scale
AIML Announces the Conclusion of Consulting Agreement and Leadership Transition for President & Chief Commercial Officer
Join AIML's Live Shareholder Update with Chairman & CEO Paul Duffy
AIML subsidiary NeuralCloud Solutions Signs Commercial Term Sheet with Culminate H Labs to Deploy MaxYield(TM) and Insight360(TM) into INTRINSICA's DNA-Guided Biofeedback Wellness Ecosystem
AIML Subsidiary NeuralCloud Enters Pilot with Cornerstone Physiotherapy to Deploy MaxYield(TM) and Insight360(TM) for Elite Athlete Cardiac Performance Testing